Axsome Therapeutics, Inc.
Senior Manager Sales,Training
New York, NY | $140K - $160K
- 51-200 employees
- Biotechnology, Health Care, Pharmaceuticals, Healthcare, Clinical Research, Life Sciences, Medical Devices & Supplies, Psychiatry
- Public Company
- Founded: 2012
- Last round: Post IPO equity
- Last round: US$ 200.0M
- New York
- Company Specialties:
Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Migraines, Fibromyalgia, and Smoking Cessation
Company information
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
